A multi-centre, open, investigator initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0.015% on the face and scalp, and 0.05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT).

CONCLUSIONS: Ingenol mebutate is effective for the treatment of AK in Asians, with tolerable safety profiles. This article is protected by copyright. All rights reserved. PMID: 29355904 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29355904?dopt=Abstract

Source: The British Journal of Dermatology - January 20, 2018 Category: Dermatology Authors: Kim YC, Yang JY, Yoon JS, Jo SJ, Ahn HH, Song KH, Lee DY, Chung KY, Won YH, Kim IH Tags: Br J Dermatol Source Type: research